Lipella Pharmaceuticals Inc
LIPO
Get informed when a big investor buys or sells
+ FollowMarket Cap$415.88K
Close$
$-0.14
207.4% downside
Current Fair Value
207.4% downsideOvervalued by 207.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $415,875.00 |
|---|---|
| Enterprise Value | $-1,591,272,125.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.79 |
| Beta | 1.5 |
| Outstanding Shares | 4,549,120 |
Return
| Return on Equity | -172.32% |
|---|---|
| Return on Assets | -109.09% |
| Return on Invested Capital | -150.13% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.26 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -7.36 |
| Enterprise Value to EBIT | 0.62 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.17 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-1.28
Average shareholder expectationRevenue Estimate
$146,000
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data